Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Psoriasis Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06172426
What this trial is testing

Incidence of Psoriatic Arthritis Among Psoriasis Patients Newly Initiated With Secukinumab in a US Claims Database and a UK Registry

Who this might be right for
Psoriatic ArthritisPsoriasis
Novartis Pharmaceuticals 1,171
Post-approval studies (Phase 4)Study completedNCT00332332
What this trial is testing

Canadian Assessment of Patient Outcomes and Effectiveness of Etanercept (Enbrel) in Psoriasis

Who this might be right for
Psoriasis
Amgen 246
Testing effectiveness (Phase 2)Study completedNCT01537432
What this trial is testing

Multiple-dose Regimen Study to Assess Effect of 12 Months of Secukinumab Treatment on Skin Response and Biomarkers in Psoriasis Patients

Who this might be right for
Psoriasis, Plaque-type Psoriasis
Novartis Pharmaceuticals 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT07839455
What this trial is testing

Oral and Topical Phytocannabinoids for Psoriasis

Who this might be right for
Psoriasis Vulgaris
Federal University of Latin American Integration 37
Not applicableUnknownNCT05598684
What this trial is testing

SAPHIR : Assessment of Predictive Factors for Persistence of Treatment After Initiation of Adalimumab With a Biosimilar (Adalimumab Fresenius KaBI or Substitution of Reference Adalimumab With the Fresenius Kabi Adalimumab Biosimilar in Patients With Chronic Inflammatory Diseases

Who this might be right for
Crohn DiseaseUlcerative ColitisRheumatoid Arthritis+2 more
Fresenius Kabi, France 600
Testing effectiveness (Phase 2)Ended earlyNCT05715125
What this trial is testing

VTX958 Versus Placebo for the Treatment of Active Psoriatic Arthritis (Tranquility-PsA)

Who this might be right for
Psoriatic Arthritis
Ventyx Biosciences, Inc 205
Post-approval studies (Phase 4)Study completedNCT02858713
What this trial is testing

Adherence in Topical Treatment of Psoriasis

Who this might be right for
Adherence
Odense University Hospital 134
Not applicableStudy completedNCT01320293
What this trial is testing

Cardiovascular Effects in Psoriasis Patients Treated With Adalimumab.

Who this might be right for
Psoriasis
University of North Carolina, Chapel Hill 18
Large-scale testing (Phase 3)Study completedNCT07008547
What this trial is testing

To Evaluate the Efficacy and Safety of Netakimab in Chinese Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
SPH-BIOCAD (HK) Limited 202
Not applicableStudy completedNCT00884468
What this trial is testing

Study Evaluating Anxiety and Depression in Patients With Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Wyeth is now a wholly owned subsidiary of Pfizer 384
Not applicableStudy completedNCT06563635
What this trial is testing

Frequency of Tuberculosis in Psoriasis Patients

Who this might be right for
Psoriasis VulgarisTuberculosis
Bezmialem Vakif University 719
Large-scale testing (Phase 3)Study completedNCT00442650
What this trial is testing

Efalizumab for Treatment of Patients With Moderate to Severe Psoriasis

Who this might be right for
Moderate to Severe Psoriasis
Merck KGaA, Darmstadt, Germany
Large-scale testing (Phase 3)Study completedNCT07746479
What this trial is testing

Evaluate the Efficacy and Safety of LZM012 ( Psoriasis )

Who this might be right for
Psoriasis
Livzon Pharmaceutical Group Inc. 244
Large-scale testing (Phase 3)Study completedNCT04930042
What this trial is testing

Efficacy, Safety, and Immunogenicity of AVT04 With Moderate-to-Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Alvotech Swiss AG 581
Not applicableActive Not RecruitingNCT06897722
What this trial is testing

Evaluation of TNF-α, IL-17A, and YKL-40 in GCF and Serum of Psoriasis Patients and Healthy Controls

Who this might be right for
Psoriasis (PsO)Periodontal Disease
Zhala Vatankha Sain 100
Testing effectiveness (Phase 2)Study completedNCT00995969
What this trial is testing

CT 327 in the Treatment of Psoriasis Vulgaris

Who this might be right for
Psoriasis
Creabilis SA 58
Post-approval studies (Phase 4)Not Yet RecruitingNCT07251556
What this trial is testing

GLP-1 Receptor Agonists in Non-diabetic Patients With Psoriatic Arthritis

Who this might be right for
Psoriasis Arthritis
Chinese University of Hong Kong 40
Large-scale testing (Phase 3)Study completedNCT01695239
What this trial is testing

Ixekizumab in Participants With Active Psoriatic Arthritis

Who this might be right for
Psoriasis, Arthritic
Eli Lilly and Company 417
Not applicableStudy completedNCT05458531
What this trial is testing

Monitoring of Inflammatory Conditions

Who this might be right for
Inflammatory DiseaseCrohn DiseaseUlcerative Colitis+6 more
University of Nottingham 664
Early research (Phase 1)Study completedNCT00417820
What this trial is testing

Study of the Safety, Tolerability and Efficacy of BCT194 in Healthy Volunteers and Patients With Psoriasis.

Who this might be right for
Psoriasis
Novartis 35
Next Page